Macquarie Stem Cells has provided this information to educate the public based on peer reviewed, published scientific and medical documents. We don’t aim to encourage consumers to seek out such treatments prior to an assessment by a health professional to determine your suitability for treatment. This is obtained directly from Queensland University through “The Conversation” website. We do not treat Multiple Sclerosis.
The brain is precious, and evolution has gone to great lengths to protect it from damage. The most obvious is our 7mm thick skull, but the brain is also surrounded by protective fluid (cerebrospinal – of the brain and spine) and a protective membrane called the meninges. Both provide further defence against physical injury.
Another protective element is the blood–brain barrier. As the name suggests, this is a barrier between the brain’s blood vessels (capillaries) and the cells and other components that make up brain tissue. Whereas the skull, meninges and cerebrospinal fluid protect against physical damage, the blood–brain barrier provides a defence against disease-causing pathogens and toxins that may be present in our blood.
The blood–brain barrier was discovered in the late 19th century, when the German physician Paul Ehrlich injected a dye into the bloodstream of a mouse. To his surprise, the dye infiltrated all tissues except the brain and spinal cord. While this showed that a barrier existed between brain and blood, it wasn’t until the 1960s researchers could use microscopes powerful enough to determine the physical layer of the blood–brain barrier.
We now know the key structure of the blood–brain barrier that offers a barrier is the “endothelial tight junction”. Endothelial cells line the interior of all blood vessels. In the capillaries that form the blood–brain barrier, endothelial cells are wedged extremely close to each other, forming so-called tight junctions.
The tight gap allows only small molecules, fat-soluble molecules, and some gases to pass freely through the capillary wall and into brain tissue. Some larger molecules, such as glucose, can gain entry through transporter proteins, which act like special doors that open only for particular molecules.
Surrounding the endothelial cells of the blood vessel are other components of the blood–brain barrier that aren’t strictly involved in stopping things getting from blood to brain, but which communicate with the cells that form the barrier to change how selective the blood–brain barrier is.
The purpose of the blood–brain barrier is to protect against circulating toxins or pathogens that could cause brain infections, while at the same time allowing vital nutrients to reach the brain.
Its other function is to help maintain relatively constant levels of hormones, nutrients and water in the brain – fluctuations in which could disrupt the finely tuned environment.
When functioning properly, the blood brain barrier lets the good things in, but prevents nasty pathogens from infecting our brain.
So what happens if the blood–brain barrier is damaged or somehow compromised?
One common way this occurs is through bacterial infection, as in meningococcal disease. Meningococcal bacteria can bind to the endothelial wall, causing tight junctions to open slightly. As a result, the blood–brain barrier becomes more porous, allowing bacteria and other toxins to infect the brain tissue, which can lead to inflammation and sometimes death.
It’s also thought the blood–brain barrier’s function can decrease in other conditions. In multiple sclerosis, for example, a defective blood–brain barrier allows white blood cells to infiltrate the brain and attack the functions that send messages from one brain cell (neuron) to another. This causes problems with how neurons signal to each other.
The blood–brain barrier is generally very effective at preventing unwanted substances from accessing the brain, which has a downside. The vast majority of potential drug treatments do not readily cross the barrier, posing a huge impediment to treating mental and neurological disorders.
Ultrasound can be used to transiently open the blood-brain barrier.
In a mouse with Alzheimer’s disease, we showed that using ultrasound to open the blood–brain barrier can improve cognition and decrease the amount of toxic plaque that accumulates in the brain. We think this may be due to the ability of ultrasound, in combination with injected gas microbubbles, to temporarily and safely open up the blood–brain barrier to let protective blood-borne factors in. Importantly, this approach didn’t damage the brain.
In a new study, we have shown that by temporarily opening the blood–brain barrier, ultrasound allows more of a therapeutic antibody into the brain, improving Alzheimer’s-like pathology and cognition more than when using ultrasound or the antibody drug in isolation.
Ultrasound is therefore a promising tool for temporarily and safely overcoming the normally very useful, but sometimes problematic, blood–brain barrier. It can be used to improve delivery of drugs to the brain, and in doing so make treatments for Alzheimer’s and other brain diseases more cost-effective.
In MS the B-cells are infected with Epstein Barr Virus (EBV) . These cells are in the blood strem but cannot attack the brain until the blood brain barrier is damaged. This damage opens the door and allows the B-cells to get into the brain and attack the myelin sheaths. We are confident that biological approaches can repair the damage in the blood brain barrier, thus shutting the door. The biological treatment can also help to repair damage to the myelin sheaths and the Oligodendrocytes that make them.
Shut the door on MS!
There is a potential for a preventative treatment, Further study is required.
Macquarie Stem Cells is designing a clinical trial for the treatment of Multiple Sclerosis.
Further information about the notes mentioned above as well as the trial details can be found in the link below.
We would also like to refer you to the published document
This article was co-authored by Dr Alan Woodruff, a science writer at the Queensland Brain Institute.
All references to the words “we” are referring to the team consisting of Rebecca M. Nisbet – Ann Van der Jeugd – Gerhard Leinenga – Harrison T. Evans – Phillip W. Janowicz – Jürgen Götz
Reference: Gotz, J. (2017). Explainer: what is the blood-brain barrier and how can we overcome it?.
[online] University of Queensland & The Conversation. Available at: http://theconversation.com/explainer-what-is-the-blood-brain-barrier-and-how-can-we-overcome-it-75454 [Accessed 11 Apr. 2017].
Tags: Macquarie Stem Cells, Dr. Bright, Osteoarthritis Treatment, Dr. Ralph Bright, Stem Cell Therapy, Stem Cell Treatment, Stem Cells for Arthritis
Remember, any surgical or invasive procedure carries risks. Before proceeding, you should seek a second opinion from an appropriately qualified health practitioner.